Moleculin Biotech, Inc. — Director's Dealing 2024

Nov 7, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moleculin Biotech, Inc. (MBRX)
CIK: 0001659617
Period of Report: 2024-11-04

Reporting Person: Yan Joy (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-11-04	Stock option (right to buy)	$2.45	A	10000	Acquired	2034-11-04	Common Stock (10000)	Direct

Footnotes

F1: The options set forth in this table vest through April 2025, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.

F2: The options were issued in connection with the reporting person's Board of Director service to the Company.